SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001410578-24-001317
Filing Date
2024-08-12
Accepted
2024-08-12 16:40:20
Documents
56
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q ckpt-20240630x10q.htm   iXBRL 10-Q 1500704
2 EX-31.1 ckpt-20240630xex31d1.htm EX-31.1 10798
3 EX-31.2 ckpt-20240630xex31d2.htm EX-31.2 10559
4 EX-32.1 ckpt-20240630xex32d1.htm EX-32.1 6857
5 EX-32.2 ckpt-20240630xex32d2.htm EX-32.2 6637
  Complete submission text file 0001410578-24-001317.txt   6086315

Data Files

Seq Description Document Type Size
6 EX-101.SCH ckpt-20240630.xsd EX-101.SCH 43614
7 EX-101.CAL ckpt-20240630_cal.xml EX-101.CAL 24082
8 EX-101.DEF ckpt-20240630_def.xml EX-101.DEF 219277
9 EX-101.LAB ckpt-20240630_lab.xml EX-101.LAB 359559
10 EX-101.PRE ckpt-20240630_pre.xml EX-101.PRE 297572
59 EXTRACTED XBRL INSTANCE DOCUMENT ckpt-20240630x10q_htm.xml XML 814928
Mailing Address 95 SAWYER ROAD SUITE 110 WALTHAM MA 02453
Business Address 95 SAWYER ROAD SUITE 110 WALTHAM MA 02453 781-652-4500
Checkpoint Therapeutics, Inc. (Filer) CIK: 0001651407 (see all company filings)

IRS No.: 472568632 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38128 | Film No.: 241197465
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)